A new trading day began on Tuesday, with Vir Biotechnology Inc (NASDAQ: VIR) stock price down -3.57% from the previous day of trading, before settling in for the closing price of $6.72. VIR’s price has ranged from $4.16 to $14.45 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -18.74%. Meanwhile, its annual earnings per share averaged 9.04%. With a float of $94.03 million, this company’s outstanding shares have now reached $139.02 million.
Let’s determine the extent of company efficiency that accounts for 408 employees.
Vir Biotechnology Inc (VIR) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Vir Biotechnology Inc is 32.42%, while institutional ownership is 54.22%. The most recent insider transaction that took place on Dec 01 ’25, was worth 1,147,786. In this transaction 10% Owner of this company sold 191,854 shares at a rate of $5.98, taking the stock ownership to the 13,728,924 shares. Before that another transaction happened on Dec 01 ’25, when Company’s Director sold 22,000 for $6.00, making the entire transaction worth $132,070. This insider now owns 1,188,391 shares in total.
Vir Biotechnology Inc (VIR) Recent Fiscal highlights
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.76 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.64 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.30% during the next five years compared to -18.74% drop over the previous five years of trading.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
Here are Vir Biotechnology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.25. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 53.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.62, a number that is poised to hit -0.65 in the next quarter and is forecasted to reach -2.93 in one year’s time.
Technical Analysis of Vir Biotechnology Inc (VIR)
Looking closely at Vir Biotechnology Inc (NASDAQ: VIR), its last 5-days average volume was 1.47 million, which is a drop from its year-to-date volume of 1.56 million. As of the previous 9 days, the stock’s Stochastic %D was 64.23%.
During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 80.03%, which indicates a significant increase from 63.98% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.43 in the past 14 days, which was higher than the 0.33 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.97, while its 200-day Moving Average is $5.62. However, in the short run, Vir Biotechnology Inc’s stock first resistance to watch stands at $6.67. Second resistance stands at $6.85. The third major resistance level sits at $7.01. If the price goes on to break the first support level at $6.33, it is likely to go to the next support level at $6.17. Now, if the price goes above the second support level, the third support stands at $5.99.
Vir Biotechnology Inc (NASDAQ: VIR) Key Stats
With a market capitalization of 901.53 million, the company has a total of 139,125K Shares Outstanding. Currently, annual sales are 74,210 K while annual income is -521,960 K. The company’s previous quarter sales were 240 K while its latest quarter income was -163,140 K.
